Athena Athena

X

Digital content for Recordati Rare Diseases

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Recordati Rare Diseases
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
100 Corporate Drive, Suite 104 Lebanon, NJ 08833
Telephone
Telephone

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-recordati-rare-diseases-pedea-5-mg-slash-ml-solution-for-injection-el-22-a-slash-45

GOVUK
27 Oct 2022

https://www.businesswire.com/news/home/20220830005004/en

BUSINESSWIRE
31 Aug 2022

https://www.businesswire.com/news/home/20220513005219/en

BUSINESSWIRE
13 May 2022

https://www.businesswire.com/news/home/20210825005202/en

BUSINESSWIRE
25 Aug 2021

https://www.businesswire.com/news/home/20210323005021/en/Recordati-Rare-Diseases-Positive-Results-From-the-Phase-III-LINC-4-Study-Presented-Today-at-the-Endocrine-Society%E2%80%99s-Annual-Meeting-Reinforce-the-Efficacy-and-Safety-of-Isturisa%C2%AE-osilodrostat-in-Cushing%E2%80%99s-Disease

BUSINESSWIRE
23 Mar 2021

https://www.businesswire.com/news/home/20210323005071/en

BUSINESSWIRE
23 Mar 2021

https://www.businesswire.com/news/home/20210323005021/en

BUSINESSWIRE
22 Mar 2021

https://www.biospace.com/article/releases/recordati-rare-diseases-announces-availability-of-cystadrops-cysteamine-ophthalmic-solution-0-37-percent-in-the-u-s-/

BIOSPACE
15 Sep 2020

https://www.prnewswire.com/news-releases/us-fda-approves-cystadrops-cysteamine-ophthalmic-solution-0-37-a-new-practical-treatment-option-for-the-ocular-manifestations-of-cystinosis-301118026.html

PRNEWSWIRE
25 Aug 2020

https://www.fiercepharma.com/pharma/cvc-aims-for-rare-disease-leadership-3-5b-recordati-buy

Carly Helfand FIERCE PHARMA
05 Jul 2018
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY